|
|
| | hVEGF-IN-1 Basic information |
| Product Name: | hVEGF-IN-1 | | Synonyms: | hVEGF-IN-1;hVEGF inhibitor 1;hVEGF-IN-1, >98%;1-Piperazinepropanamide, N-[2-[4-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-2-quinazolinyl]phenyl]-4-methyl-;Inhibitor,quinazoline,IRES-A,migration,hVEGF IN 1,hVEGFIN1,tumor,G-rich,inhibit,VEGFR,Vascular endothelial growth factor receptor,VEGF-A | | CAS: | 1637443-98-1 | | MF: | C34H43N7O2 | | MW: | 581.75 | | EINECS: | | | Product Categories: | | | Mol File: | 1637443-98-1.mol |  |
| | hVEGF-IN-1 Chemical Properties |
| Boiling point | 710.9±60.0 °C(Predicted) | | density | 1.188±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 25 mg/mL (42.97 mM);Water : < 0.1 mg/mL (insoluble) | | pka | 14.43±0.70(Predicted) |
| | hVEGF-IN-1 Usage And Synthesis |
| | hVEGF-IN-1 Preparation Products And Raw materials |
|